| Efficacy and safety of abemaciclib, an inhibitor of CDK4 and CDK6, for patients with breast cancer, non–small cell lung cancer, and other solid tumors A Patnaik, LS Rosen, SM Tolaney, AW Tolcher, JW Goldman, L Gandhi, ... Cancer discovery 6 (7), 740-753, 2016 | 664 | 2016 |
| Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L D Watkins, M Ru, HY Hwang, CD Kim, A Murray, NS Philip, W Kim, ... The American Journal of Human Genetics 71 (1), 143-153, 2002 | 154 | 2002 |
| Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours—a review C Yeung, J Hilton, M Clemons, S Mazzarello, B Hutton, F Haggar, ... Cancer and Metastasis Reviews 35, 427-437, 2016 | 105 | 2016 |
| Comorbidity, age and overall survival in patients with advanced pancreatic cancer–results from NCIC CTG PA. 3: a phase III trial of gemcitabine plus erlotinib or placebo MM Vickers, ED Powell, TR Asmis, DJ Jonker, JF Hilton, CJ O’Callaghan, ... European journal of cancer 48 (10), 1434-1442, 2012 | 81 | 2012 |
| Aurora kinase inhibition as an anticancer strategy JF Hilton, GI Shapiro Journal of clinical oncology 32 (1), 57-59, 2014 | 71 | 2014 |
| An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib JF Hilton, D Tu, L Seymour, FA Shepherd, PA Bradbury Lung cancer 82 (1), 136-142, 2013 | 71 | 2013 |
| Mammographic microcalcifications and breast cancer tumorigenesis: a radiologic-pathologic analysis M Naseem, J Murray, JF Hilton, J Karamchandani, D Muradali, ... BMC cancer 15, 1-9, 2015 | 67 | 2015 |
| Acquisition of metastatic tissue from patients with bone metastases from breast cancer JF Hilton, E Amir, S Hopkins, M Nabavi, G DiPrimio, A Sheikh, SJ Done, ... Breast cancer research and treatment 129, 761-765, 2011 | 56 | 2011 |
| Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis MFK Ibrahim, S Mazzarello, R Shorr, L Vandermeer, C Jacobs, J Hilton, ... Annals of Oncology 26 (11), 2205-2213, 2015 | 49 | 2015 |
| NUT midline carcinoma: an aggressive intrathoracic neoplasm SA Parikh, CA French, BA Costello, RS Marks, RS Dronca, CL Nerby, ... Journal of Thoracic Oncology 8 (10), 1335-1338, 2013 | 48 | 2013 |
| A phase II study of PF-03446962 in patients with advanced malignant pleural mesothelioma. CCTG Trial IND. 207 P Wheatley-Price, Q Chu, M Bonomi, J Seely, A Gupta, G Goss, J Hilton, ... Journal of Thoracic Oncology 11 (11), 2018-2021, 2016 | 36 | 2016 |
| Novel methodology for comparing standard-of-care interventions in patients with cancer J Hilton, S Mazzarello, D Fergusson, AA Joy, A Robinson, A Arnaout, ... Journal of Oncology Practice 12 (12), e1016-e1024, 2016 | 33 | 2016 |
| Poly (ADP-ribose) polymerase inhibitors as cancer therapy JF Hilton, MJ Hadfield, MT Tran, GI Shapiro Front Biosci 18, 1392-1406, 2013 | 29 | 2013 |
| Phase Ib study of safety and pharmacokinetics of the PI3K inhibitor SAR245408 with the HER3-neutralizing human antibody SAR256212 in patients with solid tumors VG Abramson, JG Supko, T Ballinger, JM Cleary, JF Hilton, SM Tolaney, ... Clinical Cancer Research 23 (14), 3520-3528, 2017 | 23 | 2017 |
| Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with … JF Hilton, N Bouganim, B Dong, JW Chapman, A Arnaout, F O’Malley, ... Breast cancer research and treatment 142, 143-151, 2013 | 23 | 2013 |
| Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again? RR Saleh, N Bouganim, J Hilton, A Arnaout, M Clemons Current Oncology 21 (1), e122, 2014 | 19 | 2014 |
| Future directions for bone metastasis research–highlights from the 2015 bone and the Oncologist new updates conference (BONUS) R Fernandes, P Siegel, S Komarova, J Hilton, C Addison, MFK Ibrahim, ... Journal of bone oncology 5 (2), 57-62, 2016 | 11 | 2016 |
| Primary endocrine therapy as an approach for patients with localized breast cancer deemed not to be surgical candidates J Hilton, A Arnaout, M Clemons Current Opinion in Supportive and Palliative Care 8 (1), 53-58, 2014 | 11 | 2014 |
| A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early … MFK Ibrahim, J Hilton, S Mazzarello, D Fergusson, B Hutton, A Robinson, ... Breast Cancer Research and Treatment 168, 371-379, 2018 | 9 | 2018 |
| Investigating the discernible and distinct effects of platinum‑based chemotherapy regimens for metastatic triple‑negative breast cancer on time to progression D Khalaf, JF Hilton, M Clemons, L Azoulay, H Yin, L Vandermeer, S Dent, ... Oncology letters 7 (3), 866-870, 2014 | 9 | 2014 |
